Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Jul 26.
Published in final edited form as: Pharm Biol. 2011 May 20;49(10):1046–1051. doi: 10.3109/13880209.2011.563316

Evaluation of the RNase H Inhibitory Properties of Vietnamese Medicinal Plant Extracts and Natural Compounds

Bui Huu Tai 1,2, Nguyen Duy Nhut 3, Nguyen Xuan Nhiem 1, Nguyen Huu Tung 1, Tran Hong Quang 1, Bui Thi Thuy Luyen 2, Tran Thu Huong 2, Jennifer Wilson 4, John A Beutler 4, Nguyen Manh Cuong 2,*, Young Ho Kim 1,*
PMCID: PMC3724220  NIHMSID: NIHMS491142  PMID: 21595586

Abstract

In research on anti-human immunodeficiency virus (HIV) agents from natural sources, thirty two extracts of Vietnamese plants and twenty five isolated compounds were screened for their inhibitory effect against the ribonuclease H (RNase H) activity of HIV-1 reverse transcriptase and the cytopathic effect of the HIV virus. At a concentration of 50 μg/mL, eleven plant extracts and five isolated compounds inhibited over 90 percent of RNase H enzymatic activity. Of these, the methanol extracts from the leaves of Phyllanthus reticulatus and Aglaia aphanamixis highly inhibited RNase H activity by 99% and 98%, respectively. Several fucoidans isolated from seaweeds Sargassum kuetzingii, Sargassum polycystum, and Gelidiella acerosa, as well as epigallocatechin-3-gallate isolated from Camellia chinensis also showed strong inhibitory effects over ninety percent. Sixteen plant extracts with inhibition of over seventy five percent in the RNase H assay were tested in a cellular model of HIV-1 cytopathicity; four extracts showed modest activity in protecting against the cytopathic effect of the HIV virus.

Keywords: RNase H, Cytopathic, Antivirus, Vietnamese plants, Screening

Introduction

The human immunodeficiency virus (HIV) is a pathogenic retrovirus and the cause of acquired immune deficiency syndrome (AIDS). The first cases of AIDS were identified in the United States in 1981. After that, AIDS explosively developed and rapidly became an epidemic disease worldwide. Currently, the Joint United Nations Programme on HIV/AIDS (UNAIDS) estimates that 33.4 million people around the world are suffering from HIV/AIDS. The annual number of new HIV infections declined from about 3.0 million in 2001 to 2.7 million in 2008 (UNAIDS, 2009). In Asia, reported national HIV prevalence is the highest in the southeastern countries, with wide variation in epidemic trends between countries. While the epidemics in Cambodia, Myanmar, and Thailand all show recent declines in HIV prevalence, those in Indonesia and Vietnam are growing. The estimated number of people living with HIV in Vietnam has more than doubled between 2000 and 2005 from 120,000 to 260,000 (UNAIDS, 2009). However, the available antiretroviral drugs at present have fallen short of expectations in many ways. There is the problem of rapid development of resistance of the HIV virus to the drugs, thereby making them inaccessible to those who badly need them in the developing countries.

Reverse transcriptase (RT) of HIV has been demonstrated to be important for the HIV life cycle, which has made it one of the most reliable targets for potential anti-AIDS chemotherapy. This enzyme is a multifunctional enzyme exhibiting not only reverse transcript RNA-dependent DNA polymerase (RDDP) activity but also DNA-dependent DNA polymerase (DDDP) and inherent ribonuclease H (RNase H) activities. The DNA polymerizing functions, together with the RNase H function, are responsible for converting the viral genomic RNA into proviral double-strand DNA. Inhibition the catalytic functions of RT interferes with virus production. Inhibitors of RT have been classified in two broad groups, nucleoside analogues and non-nucleoside inhibitors, with different inhibitory mechanisms, and both types have been found useful as therapeutics (Cruchaga et al., 2007). Unfortunately, their use for treatment of AIDS patients is limited due to the emergence of viral cross-resistance and cellular toxicity. Therefore the development of specific and potent antiviral drugs to restrain infection by HIV-1 still remains an urgent need.

Herein, we report on the investigation of thirty two extracts and twenty five natural compounds from Vietnamese plants for their inhibitory effects against HIV-1 RNase H activity and their activity in reversing the cytopathic effect of the HIV virus.

Material and methods

Materials and preparation of samples

All plants were collected in the different geographical zones of Vietnam. The plants were botanically identified by Prof. Ngo Van Trai, at the National Institute of Medicinal Materials (NIMM), Ministry of Health, Hanoi, Vietnam. Voucher specimens were deposited in the herbarium of the NIMM. The collected plant samples were dried in the shade and ground to a powder. Twenty grams of each dried plant sample was ultrasonically extracted in 100 ml of different solvents at room temperature for three times and filtered. The filtered solutions were combined and evaporated in vacuo to give the plants extracts. Natural compounds were obtained from several plants as previously published (Cuong et al., 2006; Cuong and Tuan, 2006; Nhut et al., 2007; Cuong et al., 2010b). The plant extracts and natural products were dissolved in dimethyl sulfoxide (DMSO) for bioassay.

Reagents

The oligonucleotides 5′-GAU CUG AGC CUG GGA GCU-fluorescein-3′ and 5′-Dabcyl-AGC TCC CAG GCT CAG ATC-3′ were synthesized and provided as the annealed RNA/DNA hybrid by TriLink Biotechnologies (San Diego, CA). The oligonucleotides 5′-(rA)22-fluorescein-3′ and 5′-Dabcyl-(dT)22-3′ were products of Dharmacon (Lafayette, CO) and Midland Certified Reagent Co. (Midland, TX), respectively. The hybrid heteroduplex was formed by mixing 5′-(rA)22-fluorescein-3′ and 5′-Dabcyl-(dT)22-3′ dissolved in 50 mM Tris, pH 8.0, containing 60 mM KCl, in a ratio of 1:1.2 followed by heating at 90°C for 5 min and slow cooling to room temperature. Aliquots of stock hybrid homoduplex were stored at −20 °C until use. Recombinant wild-type p66/p51 HIV-1 RT was overexpressed and purified as described (Fletcher et al., 1996).

Biological Testing

Spectroscopic measurements

Details of the RNase H FRET assay have been previously described (Parniak et al., 2003). Inhibition assays in 96-well microplates were carried out using a SpectraMax Gemini XS dual-scanning microplate spectrofluorometer (Molecular Devices, Sunnyvale, CA). Assays in 384-well microplates were performed using a Victor2V multilabel plate reader (Perkin–Elmer Life Sciences, Boston, MA).

Microplate assay of RNase H activity

Assays were carried out in a total volume of 100 μL of 50 mM Tris, pH 8.0, containing 60 mM KCl and 5 mM MgCl2, using final concentrations of 0.25 μM RNA/DNA hybrid and 1.0 nM recombinant p66/p51 HIV-1 RT. Stock solutions of the RNA/DNA hybrid and HIV-1 RT were diluted to the appropriate concentration immediately before use.

Reactions were started by the addition of HIV-1 RT and allowed to proceed at 37 °C for 30 min. Reactions were quenched by the addition of 50 μL of 0.5 M EDTA, pH 8.0. Fluorescence intensity in each well was assessed using an excitation wavelength of 490 nm and an emission wavelength of 528 nm, with cutoff filter set to 515 nm. To assess the effect of inhibitors, 1 μL of inhibitor in DMSO was added to the microplate well prior to the addition of substrate and RT solutions (Parniak et al., 2003)

HIV-1 cytopathicity assay

Samples were tested in duplicate dose response format using HIV-1RF in CEM-SS cells by a previously published method (Weislow et al., 1989). Extracts were dissolved in DMSO at 20 mg/mL, and diluted 1:200 into the assay plates, yielding a final top concentration of 100 μg/mL, with eight 2-fold dilutions to a low dose of 0.78 μg/mL.

Statistical Analysis

Statistical analysis was performed using the spreadsheet program Excel (Microsoft Office 2007). The data are the mean of three repeated experiments in triplicate. Values varied by no more than 5% between experiments.

Results and discussion

In the aim of our studies to discover active anti-HIV substances, 32 plants extracts and 25 compounds from natural sources were screened for RNase H enzymatic inhibition. The RNase H inhibition was measured using a FRET assay which has been previously described (Parniak et al., 2003). Using this method, the Vietnamese medicinal plants screened for RNase H inhibition are shown in Table 1. Among samples examined, the extracts of Aglaia aphanamixis, Bousingonia mekongense, Camellia chinensis, Eurya annamensis, Eurya ciliata, Fissistigma polyanthoides, Goniothalamus gracillipes, and Phyllanthus reticulatus showed over 90 % inhibitory effect on RNase H at the concentration of 50 μg/mL. The remaining samples exhibited moderate but significant inhibitory activity (56–89%). In the highly inhibitory plants, A. aphanamixis, B. mekongense, C. chinensis, and G. gracillipes have not previously been reported in either phytochemical or biological studies. E. ciliata and E. annamensis have been found to contain triterpene fatty acid esters and flavonoids such as apigenin, chrysoeriol, and quecitrin which were found to exhibit considerable monoamine oxygenase (MAO) inhibitory activity (Cuong et al., 2006; Cuong and Tuan, 2006). Chrysoeriol from E. ciliata also was found to enhance the proliferation and differentiation of osteoblastic MC3T3-E1 cells (Tai et al., 2009). In considering effect of these plants on the anti-HIV screening, 50 μg/mL of the methanol extracts of leaves and stem of P. reticulatus were the most active against RNase H, with inhibition of 99% and 96 %, respectively. In folk remedies, P. reticulatus is used for a variety of ailments including smallpox, syphilis, asthma, diarrhoea, and bleeding from gums. It also is claimed to have anti-diabetic activity in tribal areas (Kumar et al., 2008). Phyllanthus species have been found to contain bioactive alkaloids, flavonoids, lignan, phenol and terpenes (Lam et al., 2007). Some reports have demonstrated its anti-plasmodial activity (Omulokoli et al., 1997) and antidiabetic activity (Kumar et al., 2008). However, there are no reports on its inhibitory effect against RNase H.

Table 1.

RNase H inhibitory effect of Vietnamese medicinal plant extracts

No. Botanical name Codes Family name Part used(*) Extract RNase H inhibition (% at 50 μg/mL) HIV-1 EC50 (μg/mL) HIV-1 IC50 (μg./mL)
1 Aglaia aphanamixis VHKC-0063 Meliaceae L MeOH 98 n.p. 8.9
2 Bousingonia mekongense VHKC-0049 Apocynaceae WP CHCl3 97 n.p. 3.9
3 Bousingonia mekongense VHKC-0048 Apocynaceae WP n-Hexane 17 --- ---
4 Buddlejia officinalis VHKC-0058 Loganiaceae F EtOAc 63 --- ---
5 Buddlejia officinalis VHKC-0011 Loganiaceae F Water 32 --- ---
6 Buddlejia officinalis VHKC-0012 Loganiaceae F MeOH 2 --- ---
7 Camelia chinensis VHKC-0019 Theaceae L EtOAC 90 n.p. 2.1
8 Celastrus orbiculata VHKC-0043 Celastraceae L BuOH 78 44.9 >100
9 Celastrus orbiculata VHKC-0042 Celastraceae L EtOAc 89 n.p. 33.0
10 Eurya annamensis VHKC-0062 Theaceae L MeOH 93 n.p. 7.6
11 Eurya ciliata VHKC-0054 Theaceae L MeOH 96 12.1 15.9
12 Fissistigma polyanthoides VHKC-0052 Annonaceae L MeOH 95 n.p. 17.8
13 Fissistigma polyanthoides VHKC-0053 Annonaceae SB MeOH 95 n.p. 28.1
14 Glycosmis stenocarpa VHKC-0057 Rutaceae S MeOH 77 7.1 16.3
15 Goniothalamus gracillipes VHKC-0039 Annonaceae L n-Hexane 56 --- ---
16 Goniothalamus gracillipes VHKC-0040 Annonaceae L CHCl3 79 n.p. 3.4
17 Goniothalamus gracillipes VHKC-0041 Annonaceae L EtOH 97 n.p. 3.5
18 Goniothalamus tamirensis VHKC-0037 Annonaceae L CHCl3 66 --- ---
19 Goniothalamus tamirensis VHKC-0038 Annonaceae L EtOH 47 --- ---
20 Goniothalamus tamirensis VHKC-0036 Annonaceae L n-Hexane 38 --- ---
21 Goniothalamus vietnamensis VHKC-0050 Annonaceae L MeOH 81 n.p. 11.7
22 Goniothalamus vietnamensis VHKC-0051 Annonaceae R MeOH 17 --- ---
23 Panax stipuleanatus VHKC-0044 Araliaceae Rh MeOH 31 --- ---
24 Peristrophe roxburghiana VHKC-0013 Acanthaceae L Water 6 --- ---
25 Phyllanthus reticulatus VHKC-0055 Euphorbiaceae L MeOH 99 5.6 6.3
26 Phyllanthus reticulatus VHKC-0056 Euphorbiaceae S MeOH 96 n.p. 20.8
27 Schefflera leucantha VHKC-0045 Araliaceae L CH2Cl2 66 --- ---
28 Strobilanthes cusia VHKC-0016 Acanthaceae L CH2Cl2 67 --- ---
29 Strobilanthes cusia VHKC-0017 Acanthaceae L EtOAc 92 n.p. 17.1
30 Strobilanthes cusia VHKC-0018 Acanthaceae L BuOH 42 --- ---
31 Trichosanthes kirilowii VHKC-0047 Cucurbitaceae R Water 8 --- ---
32 Trichosanthes kirilowii VHKC-0046 Cucurbitaceae R CH2Cl2 13 --- ---
(*)

B: bark, F: flowers, L: leaves, R: root, Rh: rhizome, S: stem, SB: stem bark, WP: whole plant; n.p. no protection from the cytopathic effect of the virus (inactive)

To further evaluate the plant extracts, those which inhibited RNase H in the enzymatic assay by >75 percent were tested in a cellular model of HIV-1 cytopathicity. Dose-response curves of each sample were constructed at eight different concentrations in the range of 0.78–100 μg/mL to obtained EC50 and IC50 values. Of the 16 extracts tested, only four showed significantly protection against the viral cytopathic effect. These were the BuOH extract of Celastrus orbiculata leaves, and the MeOH extracts of Glycosmis stenocarpa stems, E. ciliata leaves, and P. reticulatus leaves. (Table 1).

Similarly, twenty five isolated or semi-synthetic compounds from natural sources were also tested in the enzymatic assay. At the concentration of 50 μg/mL, almost half of these samples showed potent inhibition of activity with a range of 49–97% (table 2). Of these, several fucoidan compounds, epigallocatechin-3-gallate (EGCG), and indirubin-3′-oxime exhibited higher effect with inhibition values over 80% at the tested concentration. EGCG is the most abundant catechin in green tea, and is also a potent antioxidant that may have therapeutic properties for many disorders including cancer (Katiyar et al., 2007). There has been research investigating the benefit of EGCG from green tea in the treatment of HIV infection. It has been shown to reduce plaques related to AIDS-related dementia as well as to block gp120. More research on EGCG and HIV is currently underway (Williamson et al., 2006). In considering effects on RNase H activity, EGCG exhibited strong inhibition and it may be the major compound causing high activity of green tea extract, as well as C. chinensis. The fucoidan compounds isolated from seaweeds also showed strong activity. Pharmaceutical research has been done on fucoidans, which are now being marketed as nutraceuticals and food supplements. Others reports indicated that fucoidan compounds can induce apoptosis in human lymphoma cell lines, and inhibit hyperplasia in rabbits (Aisa et al., 2004). Finally, the active compound indirubin-3′-oxime is now considered as new class of compound for treatment of cancer, especially leukemia and other immunological diseases (Kagialis-Girard et al., 2007). Indirubin-3’-oxime was synthesized by a condensation reaction between hydroxylamine and indirubin. Indirubin can be easily prepared from the leaves of several plants, such as Polygonum tinctorium (Polygonaceae), Isatis indigotica (Bassicaceae), Indigofera suffrutticosa (Fabaceae), Indigofera tinctoria (Fabaceae) and Strobilanthes cusia (Acanthaceae) (Cuong et al., 2010a; Cuong et al., 2010b). Recently, indirubin-3′-oxime was found to induce cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells (Kameswaran and Ramanibai, 2009). In the effects on RNase H activity, indirubin-3′-oxime exhibited inhibition of 82% at the concentration of 50 μg/mL. Based on this result, indirubin-3′-oxime and its derivatives may have potential to be developed as cancer drugs as well as for antiviral disease.

Table 2.

RNase H inhibitory effect of some natural compounds

No. Product name Sources
RNase H inhibition (%)
Botanical name Family name
1 Chalcon Carya tonkinensis Juglandaceae 12
2 Chrysoeriol Eurya cilliata Theaceae 49
3 Epigallocatechin-3-gallate Camelia chinensis Theaceae 93
4 Fucoidan Sargassum kuetzingii Sargassaceae 96
5 Fucoidan Ulva reticulata Ulvaceae 32
6 Fucoidan Gracilaria fisheri Gracilariaceae 77
7 Fucoidan Gracilaria firma Gracilariaceae 26
8 Fucoidan Ulva fenestrata Ulvaceae 49
9 Fucoidan Gracilaria tenuistipitata Gracilariaceae 21
10 Fucoidan Sargassum xuanmaii Sargassaceae 85
11 Fucoidan Gracilaria bailimiae Gracilariaceae 29
12 Fucoidan Gelidiella acerosa Gelidiaceae 91
13 Fucoidan Gracilaria asiatica Gracilariaceae 21
14 Fucoidan Sargassum polycystum Phaeophyceae 67
15 Fucoidan Sargassum polycystum Phaeophyceae 92
16 Fucoidan Sargassum polycystum Phaeophyceae 97
17 Glypetelotine Glycosmis petelotii Rutaceae −6
18 1-Hydroxy-3-methyl carbazole Glycosmis stenocarpa Rutaceae 49
19 Indigo naturalis Strobilanthes cusia Acanthaceae 67
20 Indirubin-3′-oxime Strobilanthes cusia Acanthaceae 82
21 Linarin Buddleja officinalis Loganiaceae 2
22 Murrayafoline-A Glycosmis stenocarpa Rutaceae 42
23 Quercitrin Eurya cilliata Theaceae 31
24 Sciadopitysin Taxus chinensis Taxaceae 76
25 Ursolic acid Bousingonia mekongense Apocynaceae 49

Conclusion

Fifty seven plant samples including extracts of Vietnamese plants and natural compounds were screened for their inhibitory effect against the ribonuclease H (RNase H) activity of HIV-1 reverse transcriptase. Of those, at the concentration of 50 μg/mL, methanol extracts from the leaves of P. reticulatus and A. aphanamixis demonstrated the strongest RNase H activity (99% and 98%, respectively). The extracts of B. mekongense, C. chinensis, E. annamensis, E. ciliata, G. gracillipes, and F. polyanthoides also showed highly inhibitory effects against RNase H activity with inhibition values of more than 90%. Natural compounds such as epigallocatechin-3-gallate isolated from C. chinensis, fucoidans separated from seaweeds Sargassum kuetzingii, Sargassum polycystum, Gelidiella acerosa, and indirubin-3′-oxime inhibited RNase H activity with the inhibition values over 90 percent. Four of the plant extracts had moderate activity in an HIV-1 cytopathicity assay.

Acknowledgments

We thank the Ministry of Science and Technology, Vietnam, for financial support in form of the Vietnam-Korea International Collaboration Project (No. 30/823/2007/HD-NDT). This work was supported partly by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093815), Republic of Korea. This research was also supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.

References

  1. Aisa Y, Miyakawa Y, Nakazato T, Shibata H, Saito K, Ikeda Y, Kizaki M. Fucoidan induces apoptosis of human HS - Sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways. Am J Hematol. 2004;78:7–14. doi: 10.1002/ajh.20182. [DOI] [PubMed] [Google Scholar]
  2. Cruchaga C, Anso E, Font M, Martino VS, Rouzaut A, Martinez-irujo JJ. A new strategy to inhibit the excision reaction catalysed by HIV-1 reverse transcriptase: compounds that compete with the template-primer. Biochem J. 2007;405:165–171. doi: 10.1042/BJ20061831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cuong NM, Tai BH, Hoan DH, Huong TT, Kim YH, Hyun J-H, Kang H-K. Inhibitory effects of indirubin derivatives on the growth of HL-60 leukemia cells. Nat Prod Commun. 2010a;5:103–106. [PubMed] [Google Scholar]
  4. Cuong NM, Tai BH, Hoan DH, Long PQ, Choi E-M, Kim YH. Synthesis and anti-osteoporosis potential of two new indirubin -3′-oxime derivatives. J Korean Soc App Biol Chem. 2010b;53:22–26. [Google Scholar]
  5. Cuong NM, Thuy DTT, Chien NQ. Chemical constituents from the leaves of Eurya annamensis. Tap Chi Hoa Hoc. 2006;44:725–729. [Google Scholar]
  6. Cuong NM, Tuan NN. The chemical constituents of Eurya ciliate leaves. Tap Chi Hoa Hoc. 2006;44:124–127. [Google Scholar]
  7. Fletcher RS, Holleschak G, Nagy E, Arion D, Borkow G, Gu Z, Wainberg MA, Parniak MA. Single - step purification of recombinant wild - type and mutant HIV - 1 reverse transcriptase. Protein Expres Purif. 1996;7:27–32. doi: 10.1006/prep.1996.0004. [DOI] [PubMed] [Google Scholar]
  8. Kagialis-Girard S, Mialou V, Chebel A, Chien WW, Tigaud I, Mokdad F, Badiou C, Ffrench M. Inhibition of normal lymphocyte proliferation by Indirubin - 3′-monoxime: a multifactorial process. Leukemia Lymphoma. 2007;48:605–615. doi: 10.1080/10428190601059696. [DOI] [PubMed] [Google Scholar]
  9. Kameswaran TR, Ramanibai R. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells. Biomed Pharmacother. 2009;63:146–154. doi: 10.1016/j.biopha.2008.03.005. [DOI] [PubMed] [Google Scholar]
  10. Katiyar S, Elmets CA, Katiyar SK. Green tea and skin cancer : photoimmunology, angiogenesis and DNA repair. J Nutr Biochem. 2007;18:287–296. doi: 10.1016/j.jnutbio.2006.08.004. [DOI] [PubMed] [Google Scholar]
  11. Kumar S, Kumar D, Deshmukh RR, Lokhande PD, More SN, Rangari VD. Antidiabetic potential of Phyllanthus reticulatus in alloxan-induced diabetic mice. Fitoterapia. 2008;79:21–23. doi: 10.1016/j.fitote.2007.06.012. [DOI] [PubMed] [Google Scholar]
  12. Lam S-H, Wang C-Y, Chen C-K, Lee S-S. Chemical investigation of Phyllanthus reticulatus by HPLC - SPE - NMR and conventional methods. Phytochem Analysis. 2007;18:251–255. doi: 10.1002/pca.979. [DOI] [PubMed] [Google Scholar]
  13. Nhut ND, Ly BM, Cuong NM, Sung TV. Isolation and characterization of fucoidans from five Sargassum species in South Vietnam. Tap Chi Hoa Hoc. 2007;45:339–344. [Google Scholar]
  14. Omulokoli E, Khan B, Chhabra SC. Antiplasmodial activity of four Kenyan medicinal plants. J Ethnopharmacol. 1997;56:133–137. doi: 10.1016/s0378-8741(97)01521-3. [DOI] [PubMed] [Google Scholar]
  15. Parniak MA, Min K-L, Budihas SR, Le Grice SFJ, Beutler JA. A fluorescence - based high - throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity. Anal Biochem. 2003;322:33–39. doi: 10.1016/j.ab.2003.06.001. [DOI] [PubMed] [Google Scholar]
  16. Tai BH, Cuong NM, Huong TT, Choi EM, Kim JA, Kim YH. Chrysoeriol isolated from the leaves of Eurya ciliata stimulates proliferation and differentiation of osteoblastic MC3T3-E1 cells. J Asian Nat Prod Res. 2009;11:817–823. doi: 10.1080/10286020903117317. [DOI] [PubMed] [Google Scholar]
  17. Weislow OS, Kiser R, Fine DL, Bader J, Shoemaker RH, Boyd MR. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J Natl Cancer I. 1989;81:577–586. doi: 10.1093/jnci/81.8.577. [DOI] [PubMed] [Google Scholar]
  18. Williamson MP, McCormick TG, Nance CL, Shearer WT. Epigallocatechin gallate, the main polyphenol in green tea , binds to the T - cell receptor , CD4: potential for HIV-1 therapy. J Allergy Clin Immun. 2006;118:1369–1374. doi: 10.1016/j.jaci.2006.08.016. [DOI] [PubMed] [Google Scholar]

RESOURCES